Management of Teleflex Incorporated (NYSE: TFX), will be presenting at the BofA Securities 2025 Health Care Conference at the ...

Teleflex (NYSE: TFX) announced that it received FDA 510(k) clearance for expanded indications of its QuikClot Control+ hemostatic device.

Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow morning. Here’s what investors should know.

Growth Score Growth investors, on the other hand, are more concerned with a company's financial strength and health, and its future ... and surgical applications. TFX is a #3 (Hold) on the Zacks ...

Below is Validea's guru fundamental report for TELEFLEX INC (TFX). Of the 22 guru strategies we follow, TFX rates highest using our Shareholder Yield Investor model based on the published strategy ...

(RTTNews) - Teleflex (TFX) announced FDA 510(k ... Teleflex are down 0.5% in pre-market trade on Tuesday. For More Such Health News, visit rttnews.com. The views and opinions expressed herein ...

The study evaluates the biomechanical performance of Aurora Spine’s SiLO TFX™ MIS Sacroiliac Joint Fixation System compared to traditional posterolateral transosseous techniques. The SiLO TFX™ system ...

Growth Score Growth investors are more concerned with a stock's future prospects, and the overall financial health and strength ... and surgical applications. TFX is a #3 (Hold) on the Zacks ...

The study evaluates the biomechanical performance of Aurora Spine’s SiLO TFX™ MIS Sacroiliac Joint Fixation System compared to traditional posterolateral transosseous techniques.